香港专利事务

We help international companies and law firms file for patent protection in Hong Kong, whether through the registration and recordal of Chinese, European, or UK patents, or through Hong Kong's own original grant patent (OGP) system. We also provide IP support for various Hong Kong specific incentives, such as the Patent Box tax reduction scheme. We also have years of experience working with Hong Kong's various funding schemes, and help eligible applicants apply for and obtain funding support for their patenting activities.

Hong Kong Patents (Registrations, Recordals, OGP, Renewals)

Hong Kong Patent Application Grant Funding

IP Support for Patent Box

Hong Kong patent searches, patentability, infringement, FTO analyses

Other Services

构建专利组合：为创新者、公司和机构提供建议

Learn more

为投资者提供建议

Learn more

中国专利事务

Learn more

我们的新闻

查看更多
Is “Comparable” the New “Unexpected”? China’s SPC Relaxes Inventive Step Standard for Breakthrough Therapeutics2026年7月14日
No More Hindsight Bias: China’s Supreme People's Court Reins in Patent Inventiveness Assessments2026年6月25日
IP Update: China’s Supreme People’s Court Issues First Public Decision Defining China’s Inventorship Standard2026年6月1日
Breaking: China Released Drug Trial Data Protection Implementation Measures2026年5月22日
Is “Comparable” the New “Unexpected”? China’s SPC Relaxes Inventive Step Standard for Breakthrough Therapeutics2026年7月14日
No More Hindsight Bias: China’s Supreme People's Court Reins in Patent Inventiveness Assessments2026年6月25日
IP Update: China’s Supreme People’s Court Issues First Public Decision Defining China’s Inventorship Standard2026年6月1日
Breaking: China Released Drug Trial Data Protection Implementation Measures2026年5月22日
Please “Mind the Traps”: Four Common Misconceptions About Hong Kong Patents2026年4月13日
A Stratification Too Far? How the CNIPA Draws the Line on Patient Subgroups in a Recent Precision Medicine Invalidation Case2026年2月27日
What Microsoft’s Recent Patent Invalidation Case in China Teaches Us About User Interface Patents2026年1月29日
Beijing Supreme People’s Court Upholds Novo Nordisk Semaglutide Patent in China based on Post-Filing Data2026年1月23日
Top crossarrow-right